ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 118 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,987,583 | -19.8% | 6,995,861 | 0.0% | 0.71% | +10.5% |
| Q2 2023 | $26,164,520 | +26.3% | 6,995,861 | +13.1% | 0.64% | -3.9% |
| Q1 2023 | $20,719,284 | -30.4% | 6,184,861 | 0.0% | 0.67% | -26.3% |
| Q4 2022 | $29,749,181 | -15.5% | 6,184,861 | 0.0% | 0.90% | -12.9% |
| Q3 2022 | $35,192,000 | -21.8% | 6,184,861 | -2.5% | 1.04% | -33.1% |
| Q2 2022 | $45,019,000 | -1.7% | 6,340,639 | 0.0% | 1.55% | +8.5% |
| Q1 2022 | $45,779,000 | -4.8% | 6,340,639 | +17.9% | 1.43% | -6.5% |
| Q4 2021 | $48,063,000 | – | 5,376,134 | – | 1.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $4,712,400 | 33.11% |
| BML Capital Management, LLC | 2,236,239 | $8,363,534 | 7.52% |
| TANG CAPITAL MANAGEMENT LLC | 3,026,455 | $11,318,942 | 1.67% |
| Stonepine Capital Management, LLC | 752,088 | $2,812,809 | 1.02% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $9,296,286 | 0.96% |
| CM Management, LLC | 250,000 | $935 | 0.91% |
| EcoR1 Capital, LLC | 6,995,861 | $26,164,520 | 0.64% |
| Cormorant Asset Management, LP | 1,547,181 | $5,786,457 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 501,537 | $1,875,748 | 0.31% |
| Auour Investments LLC | 177,000 | $661,980 | 0.28% |